nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—corneal epithelium—type 2 diabetes mellitus	0.0731	0.426	CbGeAlD
Pentosan Polysulfate—FGF1—artery—type 2 diabetes mellitus	0.0158	0.0921	CbGeAlD
Pentosan Polysulfate—FGF1—nerve—type 2 diabetes mellitus	0.0157	0.0914	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—type 2 diabetes mellitus	0.0134	0.0778	CbGeAlD
Pentosan Polysulfate—FGF2—islet of Langerhans—type 2 diabetes mellitus	0.0102	0.0595	CbGeAlD
Pentosan Polysulfate—FGF2—adipose tissue—type 2 diabetes mellitus	0.00652	0.038	CbGeAlD
Pentosan Polysulfate—FGF1—retina—type 2 diabetes mellitus	0.0065	0.0379	CbGeAlD
Pentosan Polysulfate—FGF1—nephron tubule—type 2 diabetes mellitus	0.00612	0.0357	CbGeAlD
Pentosan Polysulfate—FGF1—cardiovascular system—type 2 diabetes mellitus	0.0055	0.032	CbGeAlD
Pentosan Polysulfate—FGF1—kidney—type 2 diabetes mellitus	0.00538	0.0313	CbGeAlD
Pentosan Polysulfate—FGF1—cortex of kidney—type 2 diabetes mellitus	0.00524	0.0305	CbGeAlD
Pentosan Polysulfate—FGF1—adipose tissue—type 2 diabetes mellitus	0.00485	0.0282	CbGeAlD
Pentosan Polysulfate—FGF1—liver—type 2 diabetes mellitus	0.0034	0.0198	CbGeAlD
Pentosan Polysulfate—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000536	0.00122	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Losartan—type 2 diabetes mellitus	0.000534	0.00121	CcSEcCtD
Pentosan Polysulfate—Jaundice—Ramipril—type 2 diabetes mellitus	0.000533	0.00121	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000533	0.00121	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000531	0.00121	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00053	0.0012	CcSEcCtD
Pentosan Polysulfate—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00053	0.0012	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000529	0.0012	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000527	0.0012	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000524	0.00119	CcSEcCtD
Pentosan Polysulfate—Myalgia—Valsartan—type 2 diabetes mellitus	0.000524	0.00119	CcSEcCtD
Pentosan Polysulfate—Sweating—Ramipril—type 2 diabetes mellitus	0.000524	0.00119	CcSEcCtD
Pentosan Polysulfate—Dizziness—Glipizide—type 2 diabetes mellitus	0.000524	0.00119	CcSEcCtD
Pentosan Polysulfate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000523	0.00119	CcSEcCtD
Pentosan Polysulfate—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000522	0.00118	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000521	0.00118	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000519	0.00118	CcSEcCtD
Pentosan Polysulfate—Myalgia—Orlistat—type 2 diabetes mellitus	0.000518	0.00118	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000516	0.00117	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000513	0.00116	CcSEcCtD
Pentosan Polysulfate—Discomfort—Orlistat—type 2 diabetes mellitus	0.000512	0.00116	CcSEcCtD
Pentosan Polysulfate—Malaise—Metformin—type 2 diabetes mellitus	0.000506	0.00115	CcSEcCtD
Pentosan Polysulfate—Alopecia—Losartan—type 2 diabetes mellitus	0.000506	0.00115	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000506	0.00115	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000504	0.00114	CcSEcCtD
Pentosan Polysulfate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000503	0.00114	CcSEcCtD
Pentosan Polysulfate—Oedema—Valsartan—type 2 diabetes mellitus	0.000503	0.00114	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000502	0.00114	CcSEcCtD
Pentosan Polysulfate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000502	0.00114	CcSEcCtD
Pentosan Polysulfate—Infection—Valsartan—type 2 diabetes mellitus	0.000499	0.00113	CcSEcCtD
Pentosan Polysulfate—Rash—Glipizide—type 2 diabetes mellitus	0.000499	0.00113	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000499	0.00113	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000499	0.00113	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000498	0.00113	CcSEcCtD
Pentosan Polysulfate—Oedema—Orlistat—type 2 diabetes mellitus	0.000497	0.00113	CcSEcCtD
Pentosan Polysulfate—Headache—Glipizide—type 2 diabetes mellitus	0.000496	0.00113	CcSEcCtD
Pentosan Polysulfate—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000495	0.00112	CcSEcCtD
Pentosan Polysulfate—Infection—Orlistat—type 2 diabetes mellitus	0.000494	0.00112	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000492	0.00112	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000491	0.00112	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000491	0.00112	CcSEcCtD
Pentosan Polysulfate—Flatulence—Losartan—type 2 diabetes mellitus	0.000491	0.00111	CcSEcCtD
Pentosan Polysulfate—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000489	0.00111	CcSEcCtD
Pentosan Polysulfate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000489	0.00111	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000488	0.00111	CcSEcCtD
Pentosan Polysulfate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000487	0.00111	CcSEcCtD
Pentosan Polysulfate—Agitation—Irbesartan—type 2 diabetes mellitus	0.000487	0.0011	CcSEcCtD
Pentosan Polysulfate—Urticaria—Glyburide—type 2 diabetes mellitus	0.000484	0.0011	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000482	0.00109	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000482	0.00109	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00048	0.00109	CcSEcCtD
Pentosan Polysulfate—Anorexia—Valsartan—type 2 diabetes mellitus	0.000479	0.00109	CcSEcCtD
Pentosan Polysulfate—Myalgia—Metformin—type 2 diabetes mellitus	0.000478	0.00108	CcSEcCtD
Pentosan Polysulfate—Malaise—Irbesartan—type 2 diabetes mellitus	0.000477	0.00108	CcSEcCtD
Pentosan Polysulfate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000475	0.00108	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000474	0.00108	CcSEcCtD
Pentosan Polysulfate—Discomfort—Metformin—type 2 diabetes mellitus	0.000472	0.00107	CcSEcCtD
Pentosan Polysulfate—Nausea—Glipizide—type 2 diabetes mellitus	0.00047	0.00107	CcSEcCtD
Pentosan Polysulfate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00047	0.00107	CcSEcCtD
Pentosan Polysulfate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000468	0.00106	CcSEcCtD
Pentosan Polysulfate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000468	0.00106	CcSEcCtD
Pentosan Polysulfate—Rash—Glimepiride—type 2 diabetes mellitus	0.000466	0.00106	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000466	0.00106	CcSEcCtD
Pentosan Polysulfate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000464	0.00105	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000464	0.00105	CcSEcCtD
Pentosan Polysulfate—Headache—Glimepiride—type 2 diabetes mellitus	0.000463	0.00105	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000462	0.00105	CcSEcCtD
Pentosan Polysulfate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000461	0.00105	CcSEcCtD
Pentosan Polysulfate—Anaemia—Losartan—type 2 diabetes mellitus	0.00046	0.00105	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000458	0.00104	CcSEcCtD
Pentosan Polysulfate—Agitation—Losartan—type 2 diabetes mellitus	0.000458	0.00104	CcSEcCtD
Pentosan Polysulfate—Oedema—Metformin—type 2 diabetes mellitus	0.000458	0.00104	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000458	0.00104	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000456	0.00104	CcSEcCtD
Pentosan Polysulfate—Infection—Metformin—type 2 diabetes mellitus	0.000455	0.00103	CcSEcCtD
Pentosan Polysulfate—Insomnia—Valsartan—type 2 diabetes mellitus	0.000455	0.00103	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000453	0.00103	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000451	0.00103	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000451	0.00102	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000451	0.00102	CcSEcCtD
Pentosan Polysulfate—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000451	0.00102	CcSEcCtD
Pentosan Polysulfate—Insomnia—Orlistat—type 2 diabetes mellitus	0.000449	0.00102	CcSEcCtD
Pentosan Polysulfate—Malaise—Losartan—type 2 diabetes mellitus	0.000449	0.00102	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000449	0.00102	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000448	0.00102	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000448	0.00102	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000447	0.00102	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000446	0.00101	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Losartan—type 2 diabetes mellitus	0.000446	0.00101	CcSEcCtD
Pentosan Polysulfate—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000445	0.00101	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000443	0.001	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000443	0.001	CcSEcCtD
Pentosan Polysulfate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000441	0.001	CcSEcCtD
Pentosan Polysulfate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000439	0.000997	CcSEcCtD
Pentosan Polysulfate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000438	0.000993	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000437	0.000993	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000437	0.000992	CcSEcCtD
Pentosan Polysulfate—Anorexia—Metformin—type 2 diabetes mellitus	0.000436	0.000991	CcSEcCtD
Pentosan Polysulfate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000435	0.000987	CcSEcCtD
Pentosan Polysulfate—Alopecia—Ramipril—type 2 diabetes mellitus	0.000434	0.000985	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000433	0.000982	CcSEcCtD
Pentosan Polysulfate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000432	0.000981	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000432	0.000981	CcSEcCtD
Pentosan Polysulfate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000431	0.000979	CcSEcCtD
Pentosan Polysulfate—Constipation—Valsartan—type 2 diabetes mellitus	0.00043	0.000976	CcSEcCtD
Pentosan Polysulfate—Infection—Irbesartan—type 2 diabetes mellitus	0.000429	0.000975	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Losartan—type 2 diabetes mellitus	0.000424	0.000963	CcSEcCtD
Pentosan Polysulfate—Myalgia—Losartan—type 2 diabetes mellitus	0.000424	0.000963	CcSEcCtD
Pentosan Polysulfate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000424	0.000962	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000423	0.00096	CcSEcCtD
Pentosan Polysulfate—Rash—Bromocriptine—type 2 diabetes mellitus	0.00042	0.000954	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00042	0.000953	CcSEcCtD
Pentosan Polysulfate—Discomfort—Losartan—type 2 diabetes mellitus	0.000419	0.000951	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000418	0.000948	CcSEcCtD
Pentosan Polysulfate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000418	0.000948	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000417	0.000947	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000417	0.000947	CcSEcCtD
Pentosan Polysulfate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000412	0.000935	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000411	0.000933	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000411	0.000933	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000409	0.000929	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000408	0.000927	CcSEcCtD
Pentosan Polysulfate—Oedema—Losartan—type 2 diabetes mellitus	0.000407	0.000923	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000406	0.000922	CcSEcCtD
Pentosan Polysulfate—Infection—Losartan—type 2 diabetes mellitus	0.000404	0.000917	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000403	0.000915	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000403	0.000915	CcSEcCtD
Pentosan Polysulfate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000399	0.000907	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000398	0.000904	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000398	0.000904	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000397	0.000902	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000396	0.0009	CcSEcCtD
Pentosan Polysulfate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000396	0.000899	CcSEcCtD
Pentosan Polysulfate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000395	0.000896	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000394	0.000894	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000393	0.000892	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000393	0.000892	CcSEcCtD
Pentosan Polysulfate—Agitation—Ramipril—type 2 diabetes mellitus	0.000393	0.000891	CcSEcCtD
Pentosan Polysulfate—Constipation—Metformin—type 2 diabetes mellitus	0.000392	0.000889	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000388	0.000881	CcSEcCtD
Pentosan Polysulfate—Anorexia—Losartan—type 2 diabetes mellitus	0.000388	0.00088	CcSEcCtD
Pentosan Polysulfate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000387	0.00088	CcSEcCtD
Pentosan Polysulfate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000387	0.000879	CcSEcCtD
Pentosan Polysulfate—Malaise—Ramipril—type 2 diabetes mellitus	0.000385	0.000875	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000385	0.000875	CcSEcCtD
Pentosan Polysulfate—Rash—Glyburide—type 2 diabetes mellitus	0.000384	0.000872	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000384	0.000872	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000382	0.000868	CcSEcCtD
Pentosan Polysulfate—Headache—Glyburide—type 2 diabetes mellitus	0.000382	0.000867	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00038	0.000864	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000377	0.000857	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000376	0.000853	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000374	0.00085	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000374	0.00085	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00037	0.000841	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00037	0.000841	CcSEcCtD
Pentosan Polysulfate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000369	0.000839	CcSEcCtD
Pentosan Polysulfate—Insomnia—Losartan—type 2 diabetes mellitus	0.000368	0.000835	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000366	0.000831	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000365	0.000829	CcSEcCtD
Pentosan Polysulfate—Urticaria—Metformin—type 2 diabetes mellitus	0.000364	0.000826	CcSEcCtD
Pentosan Polysulfate—Myalgia—Ramipril—type 2 diabetes mellitus	0.000364	0.000826	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000364	0.000826	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000363	0.000823	CcSEcCtD
Pentosan Polysulfate—Nausea—Glyburide—type 2 diabetes mellitus	0.000362	0.000822	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000362	0.000822	CcSEcCtD
Pentosan Polysulfate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000362	0.000822	CcSEcCtD
Pentosan Polysulfate—Discomfort—Ramipril—type 2 diabetes mellitus	0.000359	0.000816	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000358	0.000813	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000356	0.000808	CcSEcCtD
Pentosan Polysulfate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000356	0.000808	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000353	0.000803	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000353	0.000802	CcSEcCtD
Pentosan Polysulfate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000351	0.000798	CcSEcCtD
Pentosan Polysulfate—Oedema—Ramipril—type 2 diabetes mellitus	0.000349	0.000792	CcSEcCtD
Pentosan Polysulfate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000348	0.00079	CcSEcCtD
Pentosan Polysulfate—Constipation—Losartan—type 2 diabetes mellitus	0.000348	0.000789	CcSEcCtD
Pentosan Polysulfate—Rash—Gliclazide—type 2 diabetes mellitus	0.000345	0.000783	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000345	0.000783	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000344	0.000781	CcSEcCtD
Pentosan Polysulfate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000343	0.000779	CcSEcCtD
Pentosan Polysulfate—Headache—Gliclazide—type 2 diabetes mellitus	0.000343	0.000778	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000342	0.000775	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000341	0.000775	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00034	0.000772	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000337	0.000765	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000335	0.000761	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000333	0.000755	CcSEcCtD
Pentosan Polysulfate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000332	0.000755	CcSEcCtD
Pentosan Polysulfate—Anorexia—Ramipril—type 2 diabetes mellitus	0.000332	0.000755	CcSEcCtD
Pentosan Polysulfate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000329	0.000746	CcSEcCtD
Pentosan Polysulfate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000325	0.000738	CcSEcCtD
Pentosan Polysulfate—Pruritus—Metformin—type 2 diabetes mellitus	0.000324	0.000735	CcSEcCtD
Pentosan Polysulfate—Urticaria—Losartan—type 2 diabetes mellitus	0.000323	0.000733	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000321	0.00073	CcSEcCtD
Pentosan Polysulfate—Vomiting—Valsartan—type 2 diabetes mellitus	0.00032	0.000726	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000318	0.000723	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000318	0.000721	CcSEcCtD
Pentosan Polysulfate—Rash—Valsartan—type 2 diabetes mellitus	0.000317	0.00072	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000317	0.000719	CcSEcCtD
Pentosan Polysulfate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000316	0.000717	CcSEcCtD
Pentosan Polysulfate—Insomnia—Ramipril—type 2 diabetes mellitus	0.000315	0.000716	CcSEcCtD
Pentosan Polysulfate—Headache—Valsartan—type 2 diabetes mellitus	0.000315	0.000715	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000313	0.000711	CcSEcCtD
Pentosan Polysulfate—Rash—Orlistat—type 2 diabetes mellitus	0.000313	0.000711	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000313	0.000711	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000313	0.000711	CcSEcCtD
Pentosan Polysulfate—Headache—Orlistat—type 2 diabetes mellitus	0.000311	0.000707	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000311	0.000706	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000307	0.000697	CcSEcCtD
Pentosan Polysulfate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000306	0.000694	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000303	0.000688	CcSEcCtD
Pentosan Polysulfate—Dizziness—Metformin—type 2 diabetes mellitus	0.000303	0.000687	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.0003	0.00068	CcSEcCtD
Pentosan Polysulfate—Nausea—Valsartan—type 2 diabetes mellitus	0.000299	0.000678	CcSEcCtD
Pentosan Polysulfate—Constipation—Ramipril—type 2 diabetes mellitus	0.000298	0.000677	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000296	0.000671	CcSEcCtD
Pentosan Polysulfate—Nausea—Orlistat—type 2 diabetes mellitus	0.000295	0.00067	CcSEcCtD
Pentosan Polysulfate—Vomiting—Metformin—type 2 diabetes mellitus	0.000291	0.000661	CcSEcCtD
Pentosan Polysulfate—Rash—Metformin—type 2 diabetes mellitus	0.000289	0.000655	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000288	0.000655	CcSEcCtD
Pentosan Polysulfate—Pruritus—Losartan—type 2 diabetes mellitus	0.000288	0.000653	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000287	0.000652	CcSEcCtD
Pentosan Polysulfate—Headache—Metformin—type 2 diabetes mellitus	0.000287	0.000651	CcSEcCtD
Pentosan Polysulfate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000286	0.000649	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000285	0.000647	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000278	0.000632	CcSEcCtD
Pentosan Polysulfate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000277	0.000629	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000276	0.000626	CcSEcCtD
Pentosan Polysulfate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000275	0.000624	CcSEcCtD
Pentosan Polysulfate—Rash—Irbesartan—type 2 diabetes mellitus	0.000272	0.000619	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000272	0.000618	CcSEcCtD
Pentosan Polysulfate—Nausea—Metformin—type 2 diabetes mellitus	0.000272	0.000617	CcSEcCtD
Pentosan Polysulfate—Headache—Irbesartan—type 2 diabetes mellitus	0.000271	0.000615	CcSEcCtD
Pentosan Polysulfate—Dizziness—Losartan—type 2 diabetes mellitus	0.000269	0.00061	CcSEcCtD
Pentosan Polysulfate—Vomiting—Losartan—type 2 diabetes mellitus	0.000259	0.000587	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000257	0.000583	CcSEcCtD
Pentosan Polysulfate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000257	0.000583	CcSEcCtD
Pentosan Polysulfate—Rash—Losartan—type 2 diabetes mellitus	0.000256	0.000582	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000256	0.000582	CcSEcCtD
Pentosan Polysulfate—Headache—Losartan—type 2 diabetes mellitus	0.000255	0.000578	CcSEcCtD
Pentosan Polysulfate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000247	0.00056	CcSEcCtD
Pentosan Polysulfate—Nausea—Losartan—type 2 diabetes mellitus	0.000242	0.000548	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000239	0.000542	CcSEcCtD
Pentosan Polysulfate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000231	0.000523	CcSEcCtD
Pentosan Polysulfate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000222	0.000503	CcSEcCtD
Pentosan Polysulfate—Rash—Ramipril—type 2 diabetes mellitus	0.00022	0.000499	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00022	0.000499	CcSEcCtD
Pentosan Polysulfate—Headache—Ramipril—type 2 diabetes mellitus	0.000218	0.000496	CcSEcCtD
Pentosan Polysulfate—Nausea—Ramipril—type 2 diabetes mellitus	0.000207	0.00047	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—RELA—type 2 diabetes mellitus	5.5e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NFKB1—type 2 diabetes mellitus	5.47e-05	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOB—type 2 diabetes mellitus	5.45e-05	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.41e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.4e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AGT—type 2 diabetes mellitus	5.39e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—AKT1—type 2 diabetes mellitus	5.37e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.36e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.36e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD36—type 2 diabetes mellitus	5.36e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PPP2CA—type 2 diabetes mellitus	5.36e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2L1—type 2 diabetes mellitus	5.33e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—IL6—type 2 diabetes mellitus	5.31e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.3e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CRP—type 2 diabetes mellitus	5.3e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IRS2—type 2 diabetes mellitus	5.3e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NFKB1—type 2 diabetes mellitus	5.29e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PPP2CA—type 2 diabetes mellitus	5.29e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APOE—type 2 diabetes mellitus	5.28e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—LEP—type 2 diabetes mellitus	5.28e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CCR5—type 2 diabetes mellitus	5.26e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—IL6—type 2 diabetes mellitus	5.23e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.22e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.21e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—LPL—type 2 diabetes mellitus	5.21e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CALM1—type 2 diabetes mellitus	5.2e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.19e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.18e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—type 2 diabetes mellitus	5.17e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTHFR—type 2 diabetes mellitus	5.14e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.1e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ADCY5—type 2 diabetes mellitus	5.1e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.1e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.1e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—SRC—type 2 diabetes mellitus	5.09e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NFKB1—type 2 diabetes mellitus	5.08e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.08e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.08e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—C3—type 2 diabetes mellitus	5.08e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.02e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.01e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.98e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—type 2 diabetes mellitus	4.96e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—SRC—type 2 diabetes mellitus	4.93e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HIF1A—type 2 diabetes mellitus	4.9e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—type 2 diabetes mellitus	4.9e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IRS2—type 2 diabetes mellitus	4.89e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PRKCB—type 2 diabetes mellitus	4.89e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PPP2CA—type 2 diabetes mellitus	4.89e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ICAM1—type 2 diabetes mellitus	4.87e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2L1—type 2 diabetes mellitus	4.86e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NFKB1—type 2 diabetes mellitus	4.86e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IRS2—type 2 diabetes mellitus	4.83e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CRP—type 2 diabetes mellitus	4.83e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—type 2 diabetes mellitus	4.83e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NFKB1—type 2 diabetes mellitus	4.83e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CALM1—type 2 diabetes mellitus	4.8e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CCR5—type 2 diabetes mellitus	4.8e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOE—type 2 diabetes mellitus	4.79e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CALM1—type 2 diabetes mellitus	4.74e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—SRC—type 2 diabetes mellitus	4.74e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOA1—type 2 diabetes mellitus	4.73e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.73e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.71e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTHFR—type 2 diabetes mellitus	4.69e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.65e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GCG—type 2 diabetes mellitus	4.65e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—type 2 diabetes mellitus	4.64e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NFKB1—type 2 diabetes mellitus	4.63e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IRS1—type 2 diabetes mellitus	4.62e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.57e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.56e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TGFB1—type 2 diabetes mellitus	4.55e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—SRC—type 2 diabetes mellitus	4.53e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—INS—type 2 diabetes mellitus	4.51e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—SRC—type 2 diabetes mellitus	4.5e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HIF1A—type 2 diabetes mellitus	4.47e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—type 2 diabetes mellitus	4.46e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS2—type 2 diabetes mellitus	4.46e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IRS2—type 2 diabetes mellitus	4.46e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PRKCB—type 2 diabetes mellitus	4.46e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ICAM1—type 2 diabetes mellitus	4.44e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.44e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.43e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.39e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CALM1—type 2 diabetes mellitus	4.38e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOE—type 2 diabetes mellitus	4.36e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.36e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.36e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CASP8—type 2 diabetes mellitus	4.36e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.33e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.33e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—type 2 diabetes mellitus	4.32e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—SRC—type 2 diabetes mellitus	4.32e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOA1—type 2 diabetes mellitus	4.31e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.31e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.29e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT2—type 2 diabetes mellitus	4.28e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IRS1—type 2 diabetes mellitus	4.27e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—type 2 diabetes mellitus	4.25e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IRS1—type 2 diabetes mellitus	4.22e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.19e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SRC—type 2 diabetes mellitus	4.18e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.17e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—type 2 diabetes mellitus	4.15e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.14e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.12e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—INS—type 2 diabetes mellitus	4.09e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS2—type 2 diabetes mellitus	4.07e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.04e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LPL—type 2 diabetes mellitus	4e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CASP8—type 2 diabetes mellitus	3.97e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—type 2 diabetes mellitus	3.97e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.96e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.96e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT2—type 2 diabetes mellitus	3.95e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.95e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.95e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—type 2 diabetes mellitus	3.94e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.93e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.92e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.91e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT2—type 2 diabetes mellitus	3.9e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IRS1—type 2 diabetes mellitus	3.89e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3R1—type 2 diabetes mellitus	3.88e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.82e-05	9.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.8e-05	9.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—type 2 diabetes mellitus	3.79e-05	9.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.76e-05	9.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SERPINE1—type 2 diabetes mellitus	3.76e-05	9.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.75e-05	9.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2—type 2 diabetes mellitus	3.74e-05	9.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TGFB1—type 2 diabetes mellitus	3.74e-05	9.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—INS—type 2 diabetes mellitus	3.73e-05	9.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RELA—type 2 diabetes mellitus	3.72e-05	9.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.68e-05	9.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—type 2 diabetes mellitus	3.66e-05	9.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RELA—type 2 diabetes mellitus	3.66e-05	9.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.65e-05	9.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT2—type 2 diabetes mellitus	3.6e-05	9.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—C3—type 2 diabetes mellitus	3.6e-05	9.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3R1—type 2 diabetes mellitus	3.59e-05	9.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS3—type 2 diabetes mellitus	3.59e-05	9.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.57e-05	9.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3R1—type 2 diabetes mellitus	3.54e-05	9.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.43e-05	8.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—type 2 diabetes mellitus	3.43e-05	8.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.42e-05	8.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SERPINE1—type 2 diabetes mellitus	3.42e-05	8.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.42e-05	8.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.42e-05	8.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—type 2 diabetes mellitus	3.41e-05	8.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.36e-05	8.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.36e-05	8.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.36e-05	8.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.35e-05	8.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.35e-05	8.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RELA—type 2 diabetes mellitus	3.33e-05	8.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—type 2 diabetes mellitus	3.32e-05	8.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.31e-05	8.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—C3—type 2 diabetes mellitus	3.28e-05	8.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—type 2 diabetes mellitus	3.28e-05	8.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3R1—type 2 diabetes mellitus	3.27e-05	8.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS3—type 2 diabetes mellitus	3.27e-05	8.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.17e-05	8.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—type 2 diabetes mellitus	3.16e-05	8.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.16e-05	8.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.14e-05	8.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.13e-05	8.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.12e-05	8.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.12e-05	8.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NFKB1—type 2 diabetes mellitus	3.08e-05	7.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.07e-05	7.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—type 2 diabetes mellitus	3.07e-05	7.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.06e-05	7.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.06e-05	7.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—type 2 diabetes mellitus	3.05e-05	7.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—type 2 diabetes mellitus	3.03e-05	7.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.02e-05	7.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—type 2 diabetes mellitus	2.99e-05	7.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.99e-05	7.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.94e-05	7.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—type 2 diabetes mellitus	2.93e-05	7.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.88e-05	7.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—type 2 diabetes mellitus	2.87e-05	7.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—INS—type 2 diabetes mellitus	2.86e-05	7.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.85e-05	7.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.82e-05	7.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—type 2 diabetes mellitus	2.81e-05	7.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—type 2 diabetes mellitus	2.81e-05	7.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NFKB1—type 2 diabetes mellitus	2.81e-05	7.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—type 2 diabetes mellitus	2.8e-05	7.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.77e-05	7.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.77e-05	7.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.73e-05	7.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.68e-05	6.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—type 2 diabetes mellitus	2.65e-05	6.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.63e-05	6.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—type 2 diabetes mellitus	2.62e-05	6.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.62e-05	6.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—INS—type 2 diabetes mellitus	2.61e-05	6.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—type 2 diabetes mellitus	2.6e-05	6.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.57e-05	6.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.56e-05	6.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.53e-05	6.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.52e-05	6.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—type 2 diabetes mellitus	2.52e-05	6.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.51e-05	6.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.51e-05	6.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—type 2 diabetes mellitus	2.42e-05	6.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.4e-05	6.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—type 2 diabetes mellitus	2.37e-05	6.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.36e-05	6.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—type 2 diabetes mellitus	2.32e-05	5.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—type 2 diabetes mellitus	2.3e-05	5.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.29e-05	5.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.29e-05	5.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—type 2 diabetes mellitus	2.16e-05	5.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.16e-05	5.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.13e-05	5.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—type 2 diabetes mellitus	2.12e-05	5.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.01e-05	5.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.99e-05	5.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.97e-05	5.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.94e-05	5.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—type 2 diabetes mellitus	1.94e-05	4.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.86e-05	4.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.84e-05	4.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.82e-05	4.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.82e-05	4.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.81e-05	4.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—type 2 diabetes mellitus	1.79e-05	4.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—type 2 diabetes mellitus	1.79e-05	4.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—type 2 diabetes mellitus	1.76e-05	4.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.69e-05	4.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.66e-05	4.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.65e-05	4.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—type 2 diabetes mellitus	1.65e-05	4.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—type 2 diabetes mellitus	1.63e-05	4.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—type 2 diabetes mellitus	1.63e-05	4.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.63e-05	4.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.51e-05	3.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—type 2 diabetes mellitus	1.5e-05	3.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.48e-05	3.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.25e-05	3.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.15e-05	2.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.14e-05	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.05e-05	2.71e-05	CbGpPWpGaD
